HonorHealth Research Institute in Scottsdale is revolutionizing diabetes treatment with a groundbreaking clinical trial aimed at reducing insulin injections for type 2 diabetic children from daily to once a week.
Proven Safe and Effective Medication for Children
The study focuses on children aged 10-17 and utilizes a medication that has been proven safe and effective in adults. Led by Dr. Swain, the trial seeks to stabilize children's blood sugars over a week, ultimately reducing the need for daily doses.
Enhancing Quality of Life
Dr. Swain's main objective is to improve the quality of life for diabetic children and make treatment more manageable for both kids and parents. By offering once-a-week injections, the trial aims to ease the burden on families and enhance overall compliance with treatment regimens.
Compensation for Participants
To further encourage participation, both children and parents who join the trial at HonorHealth Research Institute in Scottsdale will be compensated. This initiative not only benefits the participants but also contributes to the advancement of diabetes care for young individuals. The innovative approach of this clinical trial holds great promise for revolutionizing diabetes treatment and offers hope for a brighter future for diabetic children.